s6y

LIPELLA PHARMACEUTICALS INC.

Ticker
LIPO
CIK
1347242
Industry
Pharmaceutical Preparations
Formerly
LIPELLA PHARMACEUTICALS INC

Financials 12

  1. 10-Q Quarterly Report for period ending Sep 30, 2025
  2. 10-Q Quarterly Report for period ending Jun 30, 2025
  3. 10-Q Quarterly Report for period ending Mar 31, 2025
  4. 10-K Annual Report for period ending Dec 31, 2024
  5. 10-Q Quarterly Report for period ending Sep 30, 2024
  6. 10-Q Quarterly Report for period ending Jun 30, 2024
  7. 10-Q Quarterly Report for period ending Mar 31, 2024
  8. 10-K Annual Report for period ending Dec 31, 2023
  9. 10-Q Quarterly Report for period ending Sep 30, 2023
  10. 10-Q Quarterly Report for period ending Jun 30, 2023

All 12 financials filings

News 50

  1. 8-K Current report filing
  2. 8-K Current report filing
  3. 8-K Current report filing
  4. 8-K Current report filing
  5. 8-K Current report filing
  6. 8-K Current report filing
  7. 8-K Current report filing
  8. 8-K Current report filing
  9. 8-K Current report filing
  10. 8-K Current report filing

All 50 news filings

Ownership 56

  1. 4 Statement of changes in beneficial ownership of securities
  2. 4 Statement of changes in beneficial ownership of securities
  3. 4 Statement of changes in beneficial ownership of securities
  4. 4 Statement of changes in beneficial ownership of securities
  5. 4 Statement of changes in beneficial ownership of securities
  6. 4 Statement of changes in beneficial ownership of securities
  7. 4 Statement of changes in beneficial ownership of securities
  8. SC 13G/A Major Shareholders
  9. SC 13G/A Major Shareholders
  10. SC 13D/A Major Shareholders

All 56 ownership filings

Prospectus 30

  1. 424B5 Prospectus filed pursuant to Rule 424(b)(5)
  2. 424B3 Prospectus filed pursuant to Rule 424(b)(3)
  3. S-3 Registration statement for specified transactions by certain issuers
  4. 424B3 Prospectus filed pursuant to Rule 424(b)(3)
  5. S-3 Registration statement for specified transactions by certain issuers
  6. 424B5 Prospectus filed pursuant to Rule 424(b)(5)
  7. S-8 Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
  8. 424B3 Prospectus filed pursuant to Rule 424(b)(3)
  9. S-3 Registration statement for specified transactions by certain issuers
  10. 424B3 Prospectus filed pursuant to Rule 424(b)(3)

All 30 prospectus filings

Proxies 9

  1. PRE 14A Preliminary proxy statement not related to a contested matter or merger/acquisition
  2. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
  3. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
  4. DEF 14A Definitive proxy statements
  5. PRE 14A Preliminary proxy statement not related to a contested matter or merger/acquisition
  6. DEF 14A Definitive proxy statements
  7. PRE 14A Preliminary proxy statement not related to a contested matter or merger/acquisition
  8. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
  9. DEF 14A Definitive proxy statements

Other 68

  1. 25-NSE Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
  2. SCHEDULE 13G/A
  3. SCHEDULE 13D/A
  4. SCHEDULE 13D/A
  5. SCHEDULE 13D/A
  6. EFFECT Notice of Effectiveness
  7. CORRESP A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
  8. D Exempt (Private) Offering
  9. UPLOAD Letter (PDF)
  10. SCHEDULE 13D/A

All 68 other filings